CAR-T Cell Therapy in China: Records Usually Needed
A record-preparation guide for international patients and families exploring CAR-T cell therapy eligibility discussion in China.
- CAR-T discussion usually requires pathology, markers, prior treatment lines, response history and current health status.
- CAR-T is not suitable for every cancer or every patient.
- Eligibility, risks, timing and expected outcomes must be assessed by qualified oncology or hematology specialists.